Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cancer mechanisms

M. Anbar, Hyperthermia of die cancerous breast — analysis of mechanism. Cancer Lett. 84, 23—29... [Pg.47]

Zhang Y and Talalay P. 1994. Anticarinogenic activities of organic isothiocyanate chemistry and mechanisms. Cancer Res 54 1976s-1981s. [Pg.51]

Freeman, D. J., et al., PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell, 2003, 3(2), 117-30. [Pg.99]

Steinmetz, K.A. and Potter, J.D., Vegetables, fruit and cancer. II. Mechanisms, Cancer Causes Control, 5, 427, 1991. [Pg.344]

Tarr, M.J., McKown, B.J. Olsen. R.G. (1988) Enhancement of murine mixed lymphocyte response by 1,1-dimethylhydrazine Characterisation and possible mechanisms. Cancer Detect. Prev., 12, 573-581... [Pg.1435]

Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, Young HA, Arany P, Green JE. 2007. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Res 67 8396-8405. [Pg.353]

Rakhmilevich, A.L., Janssen, K., Hao, Z., Sondel, P.M. and Yang, N.-S. (2000) Interleukin 12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T cell-independent mechanism. Cancer Gene Then, 7, 826-838. [Pg.372]

Adams, S., Miller, G. T., Jesson, M. I., Watanabe,T, Jones, B., Wallner, B. P. (2004). PT-100, a small molecule dipepfi-dyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. Cancer Res. 64, 5471-5480. [Pg.130]

Felicetti F, Errico MC, Bottero L, Segnahni P, Stoppacciaro A, Biffoni M, Felh N, Mania G, Petrini M, Colombo MP, Peschle C, Care A (2(X)8) The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68 2745-2754... [Pg.817]

Zhang, Y. and Talalay, P. (1994) Anticarcinogenic activities of organic isothiocyanates chemistry and mechanisms. Cancer Res., 54,19765-81S. [Pg.181]

Vineis P, Miligi L, Constantini AS. Exposure to solvents and risk of non-Hodgkin lymphoma Clues on putative mechanisms. Cancer Epidemiol Biomarkers Prev 2007 16(3) 381 4. [Pg.549]

Jaiswal, M., LaRusso, N. F., et al. (2000). Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60(1) 184—90. [Pg.26]

Hanigan, M. H., 8c Devarajan, P. (2003). Cisplatin nephrotoxicity Molecular mechanisms. Cancer Ther, 1, 47-61. [Pg.347]

Medina D, Lane HW and Tracey CM (1983) Selenium and mouse mammary tumorigenesis an investigation of possible mechanisms. Cancer Res 43 2460-2462. [Pg.1399]

A. Damert, M. Machein, G. Breier, M.Q. Fujita, D. Hanahan, W. Risau, K.H. Plate (1997). Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res., 57, 3860-3864. [Pg.126]

Marchetti, C., Migliorati, G., Moraca, R., Riccardi, C., Nicoletti, I., Fabiani, R., Mastrandrea, V., and Morozzi, G., Deoxycholic acid and SCFA-induced apoptosis in the human tumor cell- line FlT-29 and possible mechanisms. Cancer Lett., 114, 97-99, 1997. [Pg.763]

Pore N, Jiang Z, Gupta A, Cerniglia G, Kao GD, Maity A. EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-l-independent and HIF-1-dependent mechanisms. Cancer Res 2006 66 3197-3204. [Pg.550]

Sureban SM, May R, Lightfoot SA, Hoskins AB, Lerner M, Brackett DJ, Postier RG, Ramanujam R, Mohammed A, Rao CV, Wyche JH, Anant S, Houchen CW. DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Res. 2011 71 2328-38. [Pg.658]

Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy the concept of additivity. Int J Radiat Oncol Biol Phys 5 85-91 Stewart DJ, Chiritescu G, Dahrouge S, et al. (2007) Chemotherapy dose-response relationships in non-small cell lung cancer and implied resistance mechanisms. Cancer Treat Rev 33 101-137... [Pg.189]

Yee KO, Connolly CM, Pines M, Lawler J (2006) Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism. Cancer Biol Ther 5(2) 218-224. doi 2419 [pii]... [Pg.4423]

Demirpence E, Balaguer P, Trousse F, Nicolas J-C, Pons M, Gagne D (1994) Antiestrogenic effects of all-trans-xoCmoic acid and 1,25-dihydroxy vitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res 54 1458-14 ... [Pg.218]

Cui, S., Reichner, J.S., Mateo, R.B., and Albina, J.E. (1994). Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54, 2462-2467. [Pg.141]

Efferth, T. and Volm, M. (1993). Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms. Cancer Lett 70,197-202. [Pg.276]


See other pages where Cancer mechanisms is mentioned: [Pg.365]    [Pg.573]    [Pg.552]    [Pg.152]    [Pg.2880]   
See also in sourсe #XX -- [ Pg.319 ]




SEARCH



Biochemical and Molecular Mechanisms of Cancer Chemoprevention by

Bladder cancer mechanism

Breast cancer molecular mechanisms

Cancer carcinogenesis mechanism

Cancer chemoprevention mechanism-based

Cancer chemoprevention mechanisms

Cancer necrosis, mechanism

Cancer, Molecular Mechanisms of Therapy

Colorectal cancer mechanisms

Free radical mechanisms in anti-cancer drug research

Prostate cancer proliferation mechanisms

Transport mechanisms cancers

© 2024 chempedia.info